California Public Employees Retirement System’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-118,000
| Closed | -$78K | – | 3399 |
|
|
2017
Q4 | $78K | Hold |
118,000
| – | – | ﹤0.01% | 3174 |
|
|
2017
Q3 | $38K | Hold |
118,000
| – | – | ﹤0.01% | 3276 |
|
|
2017
Q2 | $54K | Hold |
118,000
| – | – | ﹤0.01% | 3269 |
|
|
2017
Q1 | $142K | Hold |
118,000
| – | – | ﹤0.01% | 3132 |
|
|
2016
Q4 | $156K | Hold |
118,000
| – | – | ﹤0.01% | 3123 |
|
|
2016
Q3 | $247K | Hold |
118,000
| – | – | ﹤0.01% | 3022 |
|
|
2016
Q2 | $190K | Hold |
118,000
| – | – | ﹤0.01% | 3149 |
|
|
2016
Q1 | $114K | Hold |
118,000
| – | – | ﹤0.01% | 3315 |
|
|
2015
Q4 | $143K | Hold |
118,000
| – | – | ﹤0.01% | 3300 |
|
|
2015
Q3 | $877K | Hold |
118,000
| – | – | ﹤0.01% | 2448 |
|
|
2015
Q2 | $844K | Buy |
118,000
+64,000
| +119% | +$499K | ﹤0.01% | 2604 |
|
|
2015
Q1 | $459K | Hold |
54,000
| – | – | ﹤0.01% | 3036 |
|
|
2014
Q4 | $459K | Hold |
54,000
| – | – | ﹤0.01% | 3036 |
|
|
2014
Q3 | $535K | Hold |
54,000
| – | – | ﹤0.01% | 2917 |
|
|
2014
Q2 | $934K | Hold |
54,000
| – | – | ﹤0.01% | 2606 |
|
|
2014
Q1 | $854K | Hold |
54,000
| – | – | ﹤0.01% | 2636 |
|
|
2013
Q4 | $1.02M | Sell |
54,000
-700
| -1% | -$13.2K | ﹤0.01% | 2544 |
|
|
2013
Q3 | $1.47M | Buy |
54,700
+9,011
| +20% | +$193K | ﹤0.01% | 2151 |
|
|
2013
Q2 | $843K | Buy |
+45,689
| New | +$807K | ﹤0.01% | 2376 |
|
California Public Employees Retirement System's RPRX Position: Q1 2018 in Review
California Public Employees Retirement System sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 118,000 shares — an estimated $78K sold.
California Public Employees Retirement System first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $1.47M in Q3 2013. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.
- California Public Employees Retirement System reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
- California Public Employees Retirement System sold 118,000 Repros Therapeutics Inc. shares in Q1 2018, an estimated $78K.
- California Public Employees Retirement System first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
- California Public Employees Retirement System's Repros Therapeutics Inc. position peaked at $1.47M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.
Based on California Public Employees Retirement System's 13F filing for Q1 2018, filed 11 May 2018.